|

Triamcinolone Acetonide- Immediate Release;TCA-IR Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 4: 1

Top Sponsors

  • University of Kansas Medical Center1

Indications

  • Osteoarthritis, Knee1
  • Arthritis1
  • Diabetes1
  • Diabetes Mellitus, Type 21

Kansas City, Kansas1 trial

Knee Osteoarthritis Treatment With Zilretta vs. Kenalog in the Context of Type II Diabetes

University of Kansas Medical Center

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.